BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
SIRT1
,
G-protein-coupled receptor binding
,
Leukemia
,
Kidney
,
Laryngoscope
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
secukinumab
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
SERPINB4
PI3
S100A12
CYP4Z2P
IL19
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL
HAY_BONE_MARROW_STROMAL
TRAVAGLINI_LUNG_PROLIFERATING_MACROPHAGE_CELL
heterocyclic compound binding
organic cyclic compound binding
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Skin lesional biopsies from Psoriasis patients after secukinumab treatment
Lesional skin of ustekinumab‑resistant psoriatic plaques treated with Secukinumab or Guselkumab
Whole skin and T-cell subsets from skin of plaque psoriasis patients treated with secukinumab
Skin biopsies of Plaque psoriasis patients treated with secukinumab
Explore Curated Studies Results
Literature
Most Relevant Literature
Secukinumab-induced IgA vasculitis in a patient with psoriatic arthritis.
Lichen planus associated with secukinumab treatment for plaque psoriasis.
Real-World Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results …
Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized Obe…
Secukinumab attenuates neuroinflammation and neurobehavior defect via PKCβ/ERK/NF-κB pathway in a ra…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Treat-to-target With Secukinumab in Axial Spondyloarthritis
Immunologic Response to Secukinumab in Plaque Psoriasis
Secukinumab for Treatment of Atopic Dermatitis
Effect of Secukinumab in the Treatment of Psoriatic Arthritis
PsA Secukinumab XCT Structural Progression Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ